Sign Up Today and Learn More About electroCore Stock
Invest in or calculate the value of your shares in electroCore or other pre-IPO companies through EquityZen's platform.
electroCore Stock
electroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
About electroCore Stock
Founded
2005
Headquarters
Basking Ridge, NJ, US
Total Funding
127M
Industries
Software, Artificial Intelligence, Data and Analytics
electroCore LLC is a U.S.-based neuroscience and bioelectronic medicine healthcare technology company dedicated to improving patient outcomes through technological advancement. The company is focused on developing its proprietary non-invasive Vagus Nerve Stimulation (nVNS) therapies for the treatment of multiple conditions in neuropsychology, metabolic disorders and immunology. The company’s initial target is the treatment of primary headache, specifically migraine and cluster headache, and the associated chronic co-morbidities of gastric motility, psychiatric, sleep, and pain disorders that drive disproportionately large direct and indirect costs within the healthcare system and society.
electroCore Press Mentions
Stay in the know about the latest news on electroCore
Electrocore (ECOR) Reaches New 52-Week High After Insider Buying Activity
BangaloreWeekly • Jun 27, 2018
Global Health Innovation Merck Buys 166666 Shares of Electrocore LLC (ECOR) Stock
StockNewsTimes • Jun 27, 2018
electroCore, Inc. Announces Closing of Initial Public Offering
GlobeNewswire (press release) • Jun 26, 2018
electroCore Management
Leadership team at electroCore
Chief Medical Officer
Peter S. Staats, MD
Chief Executive Officer
Francis Amato
Join now and verify your accreditation status to gain access to:
- electroCore Current Valuation
- electroCore Stock Price
- electroCore Management
- Available deals in electroCore and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- electroCore Cap Table and Funding History by Share Class and Liquidity Preferences
- electroCore Revenue and Financials
- electroCore Highlights
- electroCore Business Model
- electroCore Risk Factors
- electroCore Research Report from SACRA Research
Trading electroCore Stock
How to invest in electroCore stock?
Accredited investors can buy pre-IPO stock in companies like electroCore through EquityZen funds. These investments are made available by existing electroCore shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell electroCore stock?
Shareholders can sell their electroCore stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."